Concepedia

Hecun Zou

HZ

Statistics

Publications

16

Citations

416

H-Index

13

Active since

2017

Affiliations

Chongqing Medical University(Current)

Central South University

Xiangya Hospital Central South University

PharmacoGenetics (China)

University of Duisburg-Essen

Hecun Zou is an author at Chongqing Medical University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2017–2024

16

Publications

16

P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas

Hecun Zou, Chunjie Wen, Zhigang Peng et al. · Oncology Reports · 2017 · 64 citations · Full text

, , +17

lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients

Hecun Zou, Lanxiang Wu, Yonglong Yang et al. · Oncotarget · 2017 · 57 citations · Full text

, , +17

Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients

Zhigang Peng, Hui Cao, Hecun Zou et al. · Aging · 2020 · 33 citations · Full text

, , +17

SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer

Cuilin Li, Xiaowei Peng, Jing Lv et al. · Biomedicine & Pharmacotherapy · 2019 · 32 citations · Full text

, , +13

Ct-OATP1B3 promotes high-grade serous ovarian cancer metastasis by regulation of fatty acid beta-oxidation and oxidative phosphorylation

Yutang Huang, Yan Du, Yujie Zheng et al. · Cell Death and Disease · 2022 · 32 citations · Full text

, , +17

1–5 of 16